Outcomes of patients with relapsed or refractory primary mediastinal B-cell lymphoma treated with anti-CD19 CAR-T cells: CARTHYM, a study from the French national DESCAR-T registry
接受抗CD19 CAR-T细胞治疗的复发或难治性原发性纵隔B细胞淋巴瘤患者的预后：CARTHYM研究，一项来自法国国家DESCAR-T注册研究。
期刊:Hemasphere
影响因子:14.6
doi:10.1002/hem3.70091
Galtier, Jean; Mesguich, Charles; Sesques, Pierre; Dupont, Vivien; Bachy, Emmanuel; Di Blasi, Roberta; Thieblemont, Catherine; Gastinne, Thomas; Cartron, Guillaume; Brisou, Gabriel; Gros, François-Xavier; Decroocq, Justine; Morschhauser, Franck; Rubio, Marie-Thérèse; Drieu La Rochelle, Laurianne; Le Bras, Fabien; Carras, Sylvain; Chauchet, Adrien; Bay, Jacques-Olivier; Joris, Magalie; Loschi, Mickael; Tanguy-Schmidt, Aline; Marquet, Alexandra; Camus, Vincent; Le Gouill, Steven; Houot, Roch; Bouabdallah, Krimo
B细胞
T细胞
淋巴瘤
T细胞
细胞生物学
CD19
免疫/内分泌
